Business description: CARMAT

CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.

Number of employees: 162

Sales by Activity: CARMAT

Fiscal Period: December20192020202120222023

Medical Products

14K 9.33K 2.24M 477K 3.84M
See all business segments

Geographical breakdown of sales: CARMAT

Fiscal Period: December20192020202120222023

Export

- - 2.23M 205K 1.47M

France

14K 9.33K - 140K 1.33M

Unallocated

- - 8K 132K 1.04M
See all geographic segments

Managers: CARMAT

Director TitleAgeSince
Chief Executive Officer 54 2016-08-31
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer 66 2010-12-22
Chief Tech/Sci/R&D Officer - 2009-11-30
Corporate Officer/Principal - -
See CARMAT governance

Members of the board: CARMAT

Manager TitleAgeSince
Director/Board Member 54 -
Director/Board Member 67 2017-01-01
Director/Board Member 78 2017-04-19
Chairman 70 2024-06-24
Director/Board Member 62 2021-05-06
Director/Board Member 40 2021-05-06
Director/Board Member 58 2021-05-06
Director/Board Member 53 2022-12-31
Director/Board Member 57 2023-03-10
Composition of the Board of Directors

Shareholders: CARMAT

NameEquities%Valuation
2,946,954 6.621 % 3 M €
2,670,640 6 % 2 M €
2,518,344 5.658 % 2 M €
880,000 1.977 % 751 969 €
679,050 1.526 % 580 255 €
List of CARMAT shareholders

Holdings: CARMAT

NameEquities%Valuation
6,4740.01%5,532 $

Company details: CARMAT

Carmat SA

36, avenue de l'Europe Immeuble l'Etendard Energy III

78140, Vélizy-Villacoublay

+33 1 39 45 64 50

http://www.carmatsa.com
address CARMAT(ALCAR)

Medical Devices & Implants

Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+4.60%+12.50%-78.52%-92.41% 51.44M
+0.08%-2.52%+13.63%+54.16% 147B
+0.56%+0.10%-6.43%-14.93% 11.03B
+1.49%-5.84%+56.25%+171.76% 7.92B
+3.84%+9.06%-19.45%-39.09% 7.27B
-1.69%+1.62%-2.14%-18.13% 5.55B
+0.75%-.--%+4.61%+33.62% 3.63B
-0.41%-2.55%-27.04%-64.63% 2.5B
-3.24%-1.69%-19.57%-16.89% 2B
+0.55%-1.08%+21.77%-27.94% 1.94B
Average +0.54%-1.36%-5.69%-1.45% 18.89B
Weighted average by Cap. +0.24%-3.16%+11.50%+45.74%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0.8700EUR
Average target price
4.680EUR
Spread / Average Target
+437.93%
Consensus

Quarterly revenue - Rate of surprise